Patents for Innovation

Preserving Strong Patents to Ensure Investment in New Therapies

At a time when we need to be creating incentives for investment in innovative therapies, Congress is considering patent reform legislation that could make future advances in treating epilepsy all too rare. A strong and secure patent system that encourages investments in innovative treatments and devices is critical for the millions of Americans waiting for breakthrough therapies and a cure to live their lives to their fullest potential.

Patient Community Supports a Strong Patent System

On September 8, 2015, the Epilepsy Foundation and a diverse group of more than 100 national and state-based advocacy organizations sent a letter to the House and Senate Judiciary Committees urging Congress to amend H.R. 9 to preserve the highly-detailed and sophisticated systems designed by Hatch-Waxman and BPCIA and avoid weakening the patents that sustain medical research.


Below you can find letters, press releases, and blog posts related to this issue.

Epilepsy Foundation press release on May 21st patent reform group letter to the Hill

Guest blog post on BiotechNOW by Epilepsy Foundation President & CEO, Phil Gattone

Epilepsy Foundation press release on September 8th group letter to Congress on patent reform

In the News

Legal Newsline Article on September 8th Patent Letter

Op-ed in Newsweek by Epilepsy Foundation President & CEO, Phil Gattone

Congress must keep trolls away from medical patents


Reviewed in December 2016

Monday, September 21, 2015